Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The effect of the TP53 and RB1 mutations on the survival of hepatocellular carcinoma patients with different racial backgrounds

23 Jul 2021

Abstract excerpt

Background: Racial disparities in the survival of patients with hepatocellular carcinoma (HCC) exist. Gene mutations have a profound effect on carcinogenesis, are easily affected by environment and etiology factors, and may result in survival divergences among patients with different racial backgrounds. This report explores the effects of gene mutations on the survival of American Caucasians and Asian patients....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Hepatocellular Carcinoma Treatment and Prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34532128
DOI: 10.21037/jgo-21-312

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The effect of the TP53 and RB1 mutations on the survival of hepatocellular carcinoma patients with different racial backgroundsPMID 34532128Read ↗

Differences in somatic mutation landscape of hepatocellular carcinoma in Asian American and European American populations.Semantic proximity Read ↗

Comparative Genomic Analysis of Key Oncogenic Pathways in Hepatocellular Carcinoma Among Diverse PopulationsSemantic proximity Read ↗

Tumor suppressor gene mutations correlate with prognosis and immunotherapy benefit in hepatocellular carcinoma.Semantic proximity Read ↗

Comparative genomic analysis of key oncogenic pathways in hepatocellular carcinoma among diverse populationsSemantic proximity Read ↗

Association of survival and genomic mutation signature with immunotherapy in patients with hepatocellular carcinomaSemantic proximity Read ↗

Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinomaSemantic proximity Read ↗

Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomasSemantic proximity Read ↗

Transcriptional Landscape of Hepatocellular Carcinoma Reveals that Patient Ethnic-Origin Influences Patterns of ExpressionSemantic proximity Read ↗

LRP1B mutation: a novel independent prognostic factor and a predictive tumor mutation burden in hepatocellular carcinomaSemantic proximity Read ↗

The biology of Hepatocellular carcinoma: implications for genomic and immune therapies.Semantic proximity Read ↗

Mutational and transcriptional alterations and clinicopathological factors predict the prognosis of stage I hepatocellular carcinoma : Prediction of stage I HCC prognosis.Semantic proximity Read ↗

Identification of TP53 mutation associated-immunotype and prediction of survival in patients with hepatocellular carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.